Mazzon Giorgio, Ferretti Stefania, Serafin Emanuele, Claps Francesco, Acquati Pietro, Brusa Davide, Germinale Federico, Celentano Giuseppe, Pescuma Andrea, Fugini Andrea Vismara, Campobasso Davide, Maestroni Umberto, Costa Giovanni, Morena Tonino, Di Marco Flavia, Baudo Andrea, Creta Massimiliano, Pavan Nicola, Ticonosco Marco, Peroni Angelo, Collura Devis, Cerruto Maria Angela, Antonelli Alessandro, Carmignani Luca, Micali Salvatore, Trombetta Carlo, Muto Giovanni, Celia Antonio
Department of Urology, AULSS7 Pedemontana, San Bassiano Hospital, Bassano del Grappa, Italy.
Department of Urology, University Hospital of Pama, Parma, Italy.
Curr Urol. 2024 Dec;18(4):301-306. doi: 10.1097/CU9.0000000000000246. Epub 2024 Apr 13.
The coronavirus disease (COVID-19) pandemic has posed challenges to the global health care community, affecting the management of upper urinary tract stones.
This retrospective study involved 9 Italian centers. We compared the 12-month period prior to COVID-19 (March 1, 2019, to February 28, 2020; Period A) with the COVID-19 period (March 1, 2020, to February 28, 2021, Period B). This study aimed to compare outcomes during Periods A and B, specifically focusing on the overall number of treatments, rate of urgent/elective cases, and operational complexity.
A total of 4018 procedures were collected, comprising 2176 procedures during Period A and 1842 during Period B, indicating a loss of 15.35% ( < 0.001). In the elective cases, 1622 procedures were conducted in Period A, compared with 1280 in Period B, representing a 21.09% reduction in cases ( = 0.001). All types of stone treatments were affected: extracorporeal shock wave lithotripsy (-29.37%, = 0.001), percutaneous nephrolithotomy (-26.47%, = 0.008), retrograde surgeries for renal stones (-10.63%, = 0.008), and semirigid ureterolithotripsy (-24.86%, = 0.008). Waiting lists experienced significant delays during Period B. The waiting time (WT) for elective procedures increased during Period B ( < 0.001). For ureteral stones, the mean WT in Period A was 61.44 days compared with 86.56 days in Period B ( = 0.008). The WT for renal stones increased from 64.96 days in Period A to 85.66 days in Period B for retrograde intrarenal surgery ( = 0.008) and from 96.9 days to 1103.9 days ( = 0.035) for percutaneous nephrolithotomy procedures.
Our study demonstrates that COVID-19 significantly disrupted endourological services across the country. Our data underline how patients received treatment over a prolonged period, potentially increasing the risk of stone-related complications and patient discomfort.
冠状病毒病(COVID-19)大流行给全球医疗界带来了挑战,影响了上尿路结石的治疗。
这项回顾性研究涉及9个意大利中心。我们将COVID-19之前的12个月期间(2019年3月1日至2020年2月28日;A期)与COVID-19期间(2020年3月1日至2021年2月28日,B期)进行了比较。本研究旨在比较A期和B期的治疗结果,特别关注治疗总数、急诊/择期病例率和手术复杂性。
共收集到4018例手术,其中A期2176例,B期1842例,减少了15.35%(<0.001)。在择期病例中,A期进行了1622例手术,B期为1280例,病例数减少了21.09%(=0.001)。所有类型的结石治疗均受到影响:体外冲击波碎石术(-29.37%,=0.001)、经皮肾镜取石术(-26.47%,=0.008)、肾结石逆行手术(-10.63%,=0.008)和半硬性输尿管镜碎石术(-24.86%,=0.008)。B期等待名单出现了显著延迟。择期手术的等待时间(WT)在B期增加(<0.001)。对于输尿管结石,A期的平均WT为61.44天,B期为86.56天(=0.008)。肾结石的WT在逆行肾内手术中从A期的64.96天增加到B期的85.66天(=0.008),经皮肾镜取石术从96.9天增加到1103.9天(=0.035)。
我们的研究表明,COVID-19严重扰乱了全国的腔内泌尿外科服务。我们的数据强调了患者接受治疗的时间延长,这可能增加结石相关并发症和患者不适的风险。